Ian D. Dang

Array ( [id] => 5770492 [patent_doc_number] => 20050266445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Purified mammalian CTLA-8 antigens and related reagents' [patent_app_type] => utility [patent_app_number] => 11/097622 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17823 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266445.pdf [firstpage_image] =>[orig_patent_app_number] => 11097622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786139 [patent_doc_number] => 20080139468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method For Control of Invasion and Use of Adiponectin' [patent_app_type] => utility [patent_app_number] => 11/547169 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3894 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139468.pdf [firstpage_image] =>[orig_patent_app_number] => 11547169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830285 [patent_doc_number] => 07399839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Monopegylated growth hormone proteins' [patent_app_type] => utility [patent_app_number] => 11/093477 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41797 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399839.pdf [firstpage_image] =>[orig_patent_app_number] => 11093477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019340 [patent_doc_number] => 20050221359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Cospeptin, cosmedin and their uses' [patent_app_type] => utility [patent_app_number] => 11/088036 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12992 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221359.pdf [firstpage_image] =>[orig_patent_app_number] => 11088036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046526 [patent_doc_number] => 20070265200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Glycol Linked Fgf-21 Compounds' [patent_app_type] => utility [patent_app_number] => 10/592016 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9285 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265200.pdf [firstpage_image] =>[orig_patent_app_number] => 10592016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655208 [patent_doc_number] => 20060140943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Immunotherapy using modulators of notch signalling' [patent_app_type] => utility [patent_app_number] => 11/071796 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29130 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140943.pdf [firstpage_image] =>[orig_patent_app_number] => 11071796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851014 [patent_doc_number] => 20060234205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'In vitro test system for predicting patient tolerability of therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/073374 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11235 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234205.pdf [firstpage_image] =>[orig_patent_app_number] => 11073374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112980 [patent_doc_number] => 20070196895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells' [patent_app_type] => utility [patent_app_number] => 10/590212 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7824 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196895.pdf [firstpage_image] =>[orig_patent_app_number] => 10590212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020375 [patent_doc_number] => 20050222394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Dual chain synthetic heparin-binding growth factor analogs' [patent_app_type] => utility [patent_app_number] => 11/065970 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13207 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222394.pdf [firstpage_image] =>[orig_patent_app_number] => 11065970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772590 [patent_doc_number] => 20080058249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Complexes' [patent_app_type] => utility [patent_app_number] => 10/590548 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4454 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058249.pdf [firstpage_image] =>[orig_patent_app_number] => 10590548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580859 [patent_doc_number] => 20090176205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna' [patent_app_type] => utility [patent_app_number] => 10/590464 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14163 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176205.pdf [firstpage_image] =>[orig_patent_app_number] => 10590464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005889 [patent_doc_number] => 20050171202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Modulation of signal transduction' [patent_app_type] => utility [patent_app_number] => 11/062222 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13576 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171202.pdf [firstpage_image] =>[orig_patent_app_number] => 11062222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22840 [patent_doc_number] => 07794742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Devices for promoting epithelial cell differentiation and keratinization' [patent_app_type] => utility [patent_app_number] => 11/054369 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 11946 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794742.pdf [firstpage_image] =>[orig_patent_app_number] => 11054369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169699 [patent_doc_number] => 20050202479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/049518 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 53242 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202479.pdf [firstpage_image] =>[orig_patent_app_number] => 11049518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005081 [patent_doc_number] => 20050170394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'GLUT1 transporters expressed in blood brain barrier cells' [patent_app_type] => utility [patent_app_number] => 11/027742 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15208 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170394.pdf [firstpage_image] =>[orig_patent_app_number] => 11027742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005131 [patent_doc_number] => 20050170444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Methods of diagnosing and treating pre-eclampsia or eclampsia' [patent_app_type] => utility [patent_app_number] => 11/019559 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30985 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170444.pdf [firstpage_image] =>[orig_patent_app_number] => 11019559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921458 [patent_doc_number] => 20080069773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Novel Sodium Channel' [patent_app_type] => utility [patent_app_number] => 10/582531 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 30076 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069773.pdf [firstpage_image] =>[orig_patent_app_number] => 10582531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250006 [patent_doc_number] => 20050142108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Methods of modulating cytokine activity; related reagents' [patent_app_type] => utility [patent_app_number] => 11/001443 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12591 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142108.pdf [firstpage_image] =>[orig_patent_app_number] => 11001443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075228 [patent_doc_number] => 20050148496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Treatment of rheumatoid arthritis with hypoxia inducible factor-1alpha antagonists' [patent_app_type] => utility [patent_app_number] => 10/997764 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16250 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148496.pdf [firstpage_image] =>[orig_patent_app_number] => 10997764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570223 [patent_doc_number] => 07829307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Production of glucagon-like peptide 2' [patent_app_type] => utility [patent_app_number] => 10/993127 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 5 [patent_no_of_words] => 6000 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829307.pdf [firstpage_image] =>[orig_patent_app_number] => 10993127 [rel_patent_id] =>[rel_patent_doc_number] =>)